Pacira BioSciences, Inc. (PCRX) Insider Trading -- Recent Executive & Director Transactions
15 insiders reported 67 Form 4 transactions for Pacira BioSciences, Inc. (PCRX) over the past 18 months (most recent 2026-10-09). Recent activity: RIKER LAUREN (Senior Vice President, Finance) Buy 6,000 shares, RIKER LAUREN (Senior Vice President, Finance) Sell 6,000 shares, SLONIN JONATHAN (Chief Medical Officer) Sell 3,040 shares, CHRISTIE CHRISTOPHER (Director) Buy 6,405 shares, Froimson Mark (Director) Buy 6,405 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | RIKER LAUREN | Senior Vice President, Finance | Buy | 6,000 | $194,100 |
| 2026-10-09 | RIKER LAUREN | Senior Vice President, Finance | Sell | 6,000 | $217,920 |
| 2026-08-18 | SLONIN JONATHAN | Chief Medical Officer | Sell | 3,040 | $70,619 |
| 2026-06-12 | CHRISTIE CHRISTOPHER | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Froimson Mark | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Young Alethia | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Brege Laura | Director | Buy | 6,405 | $0 |
| 2026-06-12 | YANG MICHAEL J. | Director | Buy | 6,405 | $0 |
| 2026-06-12 | RIKER LAUREN | Senior Vice President, Finance | Sell | 6,115 | $143,702 |
| 2026-06-12 | BIGAL MARCELO | Director | Buy | 6,405 | $0 |
| 2026-06-12 | Hirawat Samit | Director | Buy | 6,405 | $0 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 8,528 | $190,345 |
| 2026-06-05 | RIKER LAUREN | Senior Vice President, Finance | Sell | 3,187 | $71,134 |
| 2026-06-05 | WILLIAMS KRISTEN | Chief Administrative Officer | Sell | 10,259 | $228,468 |
| 2026-06-05 | SLONIN JONATHAN | Chief Medical Officer | Sell | 4,728 | $105,529 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Buy | 12,941 | $212,879 |
| 2026-04-24 | Cross Shawn | Chief Financial Officer | Sell | 12,941 | $325,596 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 7,714 | $126,895 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 7,714 | $193,930 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 2,845 | $71,153 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 1,500 | $24,675 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Sell | 1,500 | $37,515 |
| 2026-04-22 | Cross Shawn | Chief Financial Officer | Buy | 2,845 | $46,800 |
| 2026-03-19 | Froimson Mark | Director | Sell | 500 | $10,905 |
| 2026-03-19 | Kronenfeld Mark A. | Director | Buy | 6,163 | $0 |
Source: SEC Form 4 filings · as of 2026-10-09